PUBLISHER'S NOTE. Looking to the Future.

An introduction is presented in which the editor discusses various reports within the issue on topics including malingering during the pandemic, best treatment strategies for schizophrenic patients, and factors to consider when cross-titrating antipsychotic medications.

Detalles Bibliográficos
Publicado en:Psychiatric Times Vol. 39; no. 2; p. 3
Autor principal: Hennessy Jr, Mike
Formato: Artículo
Publicado: MJH Life Sciences Feb2022
Materias:
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=155210511&site=ehost-live
header:
  @attributes:
    shortDbName: ssf
    uiTerm: 155210511
    longDbName: Social Sciences Full Text (H.W. Wilson)
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        08932905
        8MJ
      jtl: Psychiatric Times
      issn: 08932905
      maglogo: N
    pubinfo:
      dt: Feb2022
      vid: 39
      iid: 2
      pid: 54670
      pub: MJH Life Sciences
    artinfo:
      ui: 155210511
      ppf: 3
      ppct: 0
      formats:
        fmt:
          @attributes:
            type: P
            size: 110KB
      tig:
        atl: PUBLISHER'S NOTE. Looking to the Future.
      aug:
        au: Hennessy Jr, Mike
        affil: President and CEO, MJH Life Sciences®
      su:
        COVID-19 pandemic
        Serial publications
        Malingering
      sug:
        subj:
          COVID-19 pandemic
          Serial publications
          Malingering
      ab: An introduction is presented in which the editor discusses various reports within the issue on topics including malingering during the pandemic, best treatment strategies for schizophrenic patients, and factors to consider when cross-titrating antipsychotic medications.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: N
    holdings:
      @attributes:
        islocal: N